Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 421 to 435 of 664 results for kidney or kidneys or renal

  1. Non-alcoholic fatty liver disease (NAFLD): assessment and management (NG49)

    This guideline covers how to identify the adults, young people and children with non-alcoholic fatty liver disease (NAFLD) who have advanced liver fibrosis and are most at risk of further complications. It outlines the lifestyle changes and pharmacological treatments that can manage NAFLD and advanced liver fibrosis.

    NICE guideline
    Published
    6 July 2016
    View recommendations

    Sections for NG49

  2. Caval valve implantation for tricuspid regurgitation (IPG791)

    Evidence-based recommendations on caval valve implantation for tricuspid regurgitation in adults. This involves implanting valves into 1 or both caval veins without disturbing the tricuspid valve.

    Interventional procedures guidance
    Published
    21 August 2024
    View recommendations

    Sections for IPG791

  3. Cardiac assessment:- What is the clinical and cost effectiveness of cardiac assessment before transplantation?

    and impact. Source guidance details Comes from guidance Renal replacement therapy and conservative management Number NG107

    Research recommendation
    Published
    18 December 2018

  4. Alpha blockers and ureteroscopy- What is the clinical and cost effectiveness of tamsulosin as an adjunct to ureteroscopy?

    and impact. Source guidance details Comes from guidance Renal and ureteric stones: assessment and management Number NG118

    Research recommendation
    Published
    7 March 2019

  5. Timing of pre-emptive transplant:- What is the most clinical and cost-effective strategy for timing of pre-emptive transplantation?

    and impact. Source guidance details Comes from guidance Renal replacement therapy and conservative management Number NG107

    Research recommendation
    Published
    18 December 2018

  6. Frequency of review:- What is the most clinical and cost-effective frequency of review for people on peritoneal dialysis, haemodiafiltration, haemodialysis or conservative management?

    and impact. Source guidance details Comes from guidance Renal replacement therapy and conservative management Number NG107

    Research recommendation
    Published
    18 December 2018

  7. Metabolic assessment:- What is the clinical and cost effectiveness of full metabolic assessment compared with standard advice alone, in people with recurrent calcium oxalate stones?

    and impact. Source guidance details Comes from guidance Renal and ureteric stones: assessment and management Number NG118

    Research recommendation
    Published
    7 March 2019

  8. i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)

    NICE has developed a medtech innovation briefing (MIB) on i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department

    Medtech innovation briefing
    Published
    9 September 2015

  9. Acute haemodialysis versus acute peritoneal dialysis:- What is the clinical and cost effectiveness of initial haemodialysis versus initial peritoneal dialysis for people who start dialysis in an unplanned way?

    and impact. Source guidance details Comes from guidance Renal replacement therapy and conservative management Number NG107

    Research recommendation
    Published
    18 December 2018

  10. Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis (TA308)

    Evidence-based recommendations on rituximab (MabThera) with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in adults.

    Technology appraisal guidance
    Published
    26 March 2014
    View recommendations

    Sections for TA308

  11. Laparoscopic retroperitoneal lymph node dissection for testicular cancer (IPG158)

    Evidence-based recommendations on laparoscopic retroperitoneal lymph node dissection for testicular cancer. This involves using smaller openings in the skin (keyhole surgery) to remove the lymph nodes.

    Interventional procedures guidance
    Published
    22 March 2006
    View recommendations

    Sections for IPG158

  12. Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)

    Summary of the evidence on antimicrobial prescribing: delafloxacin

    Evidence summary
    Published
    5 January 2021

  13. What is the effectiveness of statins and/or other LDL-cholesterol-lowering treatment in people with type 1 diabetes?

    have increased CVD risk derived from age, sex, glycaemia, blood pressure, renal function and lipid levels as identified in...

    Research recommendation
    Published
    9 June 2015

  14. NICE recommended that clinical data, including genotype and sustained virological response at 12 weeks, are collected for all people having treatment with simeprevir in the NHS.

    guidance details Comes from guidance Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment...

    Research recommendation
    Published
    9 June 2015

  15. NICE recommends that robust evidence be generated to show the clinical effectiveness of pharmacokinetic dose adjustment of continuous infusion 5-FU in people with colorectal cancer.

    with DPD (dihydropyrimidine dehydrogenase) deficiency, people with impaired renal or liver function, people whose body surface area is...

    Research recommendation
    Published
    9 June 2015